OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma.
about
Knockdown of OCT4 suppresses the growth and invasion of pancreatic cancer cells through inhibition of the AKT pathwaySulfatase 1 (hSulf-1) reverses basic fibroblast growth factor-stimulated signaling and inhibits growth of hepatocellular carcinoma in animal modelTargeted Hsp70 expression combined with CIK-activated immune reconstruction synergistically exerts antitumor efficacy in patient-derived hepatocellular carcinoma xenograft mouse models.Expression of Oct3/4 and Nanog in the head and neck squamous carcinoma cells and its clinical implications for delayed neck metastasis in stage I/II oral tongue squamous cell carcinoma.Clinical value of octamer-binding transcription factor 4 as a prognostic marker in patients with digestive system cancers: A systematic review and meta-analysis.TLR3 agonist and Sorafenib combinatorial therapy promotes immune activation and controls hepatocellular carcinoma progressionIL-13 receptor α2 is a negative prognostic factor in human lung cancer and stimulates lung cancer growth in mice.Overexpression of microRNA-21 strengthens stem cell-like characteristics in a hepatocellular carcinoma cell line.Role of microRNA-4458 in patients with non-small-cell lung cancerSurvivin promoter-regulated oncolytic adenovirus with Hsp70 gene exerts effective antitumor efficacy in gastric cancer immunotherapy.SWIM: a computational tool to unveiling crucial nodes in complex biological networks.Multidimensional integrative analysis uncovers driver candidates and biomarkers in penile carcinoma.Distinctive expression pattern of OCT4 variants in different types of breast cancer.OCT4 spliced variants are highly expressed in brain cancer tissues and inhibition of OCT4B1 causes G2/M arrest in brain cancer cells.Positive Feedback Loop of OCT4 and c-JUN Expedites Cancer Stemness in Liver Cancer.BDE-209 inhibits pluripotent genes expression and induces apoptosis in human embryonic stem cells.Transcriptional factor OCT4 promotes esophageal cancer metastasis by inducing epithelial-mesenchymal transition through VEGF-C/VEGFR-3 signaling pathway.MiR-3613-3p affects cell proliferation and cell cycle in hepatocellular carcinoma.Correlation of Cancer Stem-Cell Markers OCT4, SOX2, and NANOG with Clinicopathological Features and Prognosis in Operative Patients with Rectal Cancer.Potential role of microRNA‑223‑3p in the tumorigenesis of hepatocellular carcinoma: A comprehensive study based on data mining and bioinformatics.Diagnostic significance and potential function of miR-338-5p in hepatocellular carcinoma: A bioinformatics study with microarray and RNA sequencing data.Deep Learning based multi-omics integration robustly predicts survival in liver cancer.A study of embryonic stem cell-related proteins in human astrocytomas: identification of Nanog as a predictor of survival.Identification of novel prognosis-related genes associated with cancer using integrative network analysis.Detection of urinary survivin using a magnetic particles-based chemiluminescence immunoassay for the preliminary diagnosis of bladder cancer and renal cell carcinoma combined with LAPTM4B.The Identification of Core Gene Expression Signature in Hepatocellular Carcinoma.
P2860
Q34000656-A9BD37C7-3763-4DA3-A255-59C3A5BE889BQ34104125-3E22529C-C18F-4515-B472-5046765289A0Q35176018-F45C6B69-57B4-4EAC-9956-0B7AD195C370Q35813876-4C4A48F8-8736-45A8-8169-15CD10C3C038Q36315148-54BCF6D8-7B9F-436F-B69E-3B2C5B46ECE8Q36413746-B19051CF-7A57-4D6F-8206-87465421278BQ36545018-F1D4951B-84B8-49C4-A4B0-FEC1B271CE5FQ37377999-45635F71-DAAF-47F4-9240-9BDD08503F88Q37407264-C635A3BE-4D23-456E-98F4-D11191FB9C37Q37649650-A5DFE6A3-0204-454E-A9B6-F3C088624F59Q37710898-8027698B-F2C4-4D80-93C0-18832C393C63Q38656476-E1C94984-4E38-4614-8420-50D3546515B3Q39215105-60100AB5-2788-4DF1-9D4A-C8D1F56964C5Q39431495-7CFCA340-A0A3-4285-B1F0-8CF84D893F48Q40637784-A392064E-58EA-41E5-AF50-704C24BFD842Q40701300-7B633A76-F2EA-4157-BDD4-27712A6F31A5Q42700855-57CF1129-C452-476D-AEFC-BDA94E3428B0Q46492647-B1F13BD2-6767-4AFB-824C-1419965C41CFQ47101770-77DA76BF-BFB6-4937-B12A-758A379F7F9EQ47365487-DAEE0FB4-D6D1-4C05-A4B6-C518736C7CE7Q47365566-D81566B1-D4B2-4C53-891C-0195C53A3C12Q47855807-B83D1494-ADFC-46A3-9229-788A66A19A11Q49030496-AC6BE669-9723-4E37-8DC0-F418BCA666D6Q49830802-DFA6DB5B-5AEC-421A-B536-3E635415B3DEQ55097812-31C7E4B4-7C67-42A9-A7D7-B08BA0637092Q55434358-73FD295B-6C46-4C7F-A1CB-ECF6A1410510
P2860
OCT4 increases BIRC5 and CCND1 expression and promotes cancer progression in hepatocellular carcinoma.
description
2013 nî lūn-bûn
@nan
2013 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2013 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
name
OCT4 increases BIRC5 and CCND1 ...... n in hepatocellular carcinoma.
@ast
OCT4 increases BIRC5 and CCND1 ...... n in hepatocellular carcinoma.
@en
OCT4 increases BIRC5 and CCND1 ...... n in hepatocellular carcinoma.
@nl
type
label
OCT4 increases BIRC5 and CCND1 ...... n in hepatocellular carcinoma.
@ast
OCT4 increases BIRC5 and CCND1 ...... n in hepatocellular carcinoma.
@en
OCT4 increases BIRC5 and CCND1 ...... n in hepatocellular carcinoma.
@nl
prefLabel
OCT4 increases BIRC5 and CCND1 ...... n in hepatocellular carcinoma.
@ast
OCT4 increases BIRC5 and CCND1 ...... n in hepatocellular carcinoma.
@en
OCT4 increases BIRC5 and CCND1 ...... n in hepatocellular carcinoma.
@nl
P2093
P2860
P356
P1433
P1476
OCT4 increases BIRC5 and CCND1 ...... n in hepatocellular carcinoma.
@en
P2093
Changqing Su
Chunguang Li
Haihua Qian
Jinghan Wang
Mengchao Wu
Shuwen Shen
Xiaoqing Jiang
P2860
P2888
P356
10.1186/1471-2407-13-82
P407
P577
2013-02-22T00:00:00Z
P5875
P6179
1044817022